160 related articles for article (PubMed ID: 29755708)
1. Growth and Endocrine Function in Tunisian Thalassemia Major Patients.
Dhouib NG; Ben Khaled M; Ouederni M; Besbes H; Kouki R; Mellouli F; Bejaoui M
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018031. PubMed ID: 29755708
[TBL] [Abstract][Full Text] [Related]
2. New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement.
Carsote M; Vasiliu C; Trandafir AI; Albu SE; Dumitrascu MC; Popa A; Mehedintu C; Petca RC; Petca A; Sandru F
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010271
[TBL] [Abstract][Full Text] [Related]
3. Detection of endocrine disorders in young children with multi-transfused thalassemia major.
Mahmoud RA; Khodeary A; Farhan MS
Ital J Pediatr; 2021 Jul; 47(1):165. PubMed ID: 34332621
[TBL] [Abstract][Full Text] [Related]
4. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
[TBL] [Abstract][Full Text] [Related]
5. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
[TBL] [Abstract][Full Text] [Related]
6. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
Soliman AT; Yassin MA; De Sanctis V
Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
[TBL] [Abstract][Full Text] [Related]
7. [Growth and endocrine function in major thalassemia].
Pérignon F; Brauner R; Souberbielle JC; de Montalembert M; Girot R
Arch Fr Pediatr; 1993 Oct; 50(8):657-63. PubMed ID: 8002739
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
Bordbar M; Bozorgi H; Saki F; Haghpanah S; Karimi M; Bazrafshan A; Zekavat OR
J Endocrinol Invest; 2019 Dec; 42(12):1467-1476. PubMed ID: 31228105
[TBL] [Abstract][Full Text] [Related]
9. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
Sharma R; Seth A; Chandra J; Gohain S; Kapoor S; Singh P; Pemde H
Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
[TBL] [Abstract][Full Text] [Related]
10. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
11. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
[TBL] [Abstract][Full Text] [Related]
12. Gonadal Hormones in Adolescent Females with β-Thalassemia in Relation to Iron Load.
Hagag AA; Badraia IM; Elfarargy MS; Abo El-Enein AM
Endocr Metab Immune Disord Drug Targets; 2016; 16(2):148-153. PubMed ID: 27150601
[TBL] [Abstract][Full Text] [Related]
13. Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province.
Abdelrazik N; Ghanem H
Hematology; 2007 Oct; 12(5):449-56. PubMed ID: 17852439
[TBL] [Abstract][Full Text] [Related]
14. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.
Angelopoulos NG; Goula A; Rombopoulos G; Kaltzidou V; Katounda E; Kaltsas D; Tolis G
J Bone Miner Metab; 2006; 24(2):138-45. PubMed ID: 16502121
[TBL] [Abstract][Full Text] [Related]
15. Endocrine profile of β-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center.
De Sanctis V; Elsedfy H; Soliman AT; Elhakim IZ; Soliman NA; Elalaily R; Kattamis C
Indian J Endocrinol Metab; 2016; 20(4):451-9. PubMed ID: 27366710
[TBL] [Abstract][Full Text] [Related]
16. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
Zervas A; Katopodi A; Protonotariou A; Livadas S; Karagiorga M; Politis C; Tolis G
Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
18. Growth, puberty and endocrine function in beta-thalassaemia major.
Low LC
J Pediatr Endocrinol Metab; 1997; 10(2):175-84. PubMed ID: 9364350
[TBL] [Abstract][Full Text] [Related]
19. Growth and endocrine function in thalassemia major in childhood and adolescence.
Delvecchio M; Cavallo L
J Endocrinol Invest; 2010 Jan; 33(1):61-8. PubMed ID: 20203539
[TBL] [Abstract][Full Text] [Related]
20. Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients.
Abdulzahra MS; Al-Hakeim HK; Ridha MM
Asian J Transfus Sci; 2011 Jul; 5(2):127-31. PubMed ID: 21897589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
